US03073E1055 - Common Stock
CENCORA INC
NYSE:COR (11/22/2024, 6:50:32 PM)
After market: 246.71 +1.69 (+0.69%)245.02
-0.67 (-0.27%)
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm is focused on improving the lives of people and animals around the world. The company is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202
P: 16107277000
CEO: Paul E. Szurek
Employees: 42000
Website: https://www.cencora.com/
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75.
In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday.
Here you can normally see the latest stock twits on COR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: